In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2729-2732

  Katiyar, S K ^a   Edlind, T D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; BENOMYL; BENZIMIDAZOLE DERIVATIVE; CAMBENDAZOLE; CARBENDAZIM; CYCLOBENDAZOLE; FENBENDAZOLE; MEBENDAZOLE; NOCODAZOLE; OXFENDAZOLE; OXIBENDAZOLE; PARBENDAZOLE; TIABENDAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; MICROSPORA; MICROSPORIDIOSIS; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030809883     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2729     Document Type: Article

References (32)

1. Aarons, E. J., D. Woodrow, W. S. Hollister, E. U. Canning, N. Francis, and B. G. Gazzard. 1994. Reversible renal failure caused by a microsporidian infection. AIDS 8:1119-1121.
2. Asmuth, D. M., P. C. DeGirolami, M. Federman, C. R. Ezralty, D. K. Pleskow, G. Desai, and C. A. Wanke. 1994. Clinical features of microsporidiosis in patients with AIDS. Clin. Infect. Dis. 18:819-825.
3. Baker, M. D., C. R. Vossbrinck, E. S. Didier, J. V. Maddox, and J. A. Shadduck. 1995. Small subunit ribosomal DNA phylogeny of various microsporidia with emphasis on AIDS related forms. J. Eukaryot. Microbiol. 42:564-570.
4. Bartlett, M. S., T. D. Edlind, M. M. Durkin, M. M. Shaw, S. F. Queener, and J. W. Smith. 1992. Antimicrotubule benzimidazoles inhibit in vitro growth of Pneumocystis carinii. Antimicrob. Agents Chemother. 36:779-782.
5. Bartlett, M. S., T. D. Edlind, C. H. Lee, R. Dean, S. F. Queener, M. M. Shaw, and J. W. Smith. 1994. Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice. Antimicrob. Agents Chemother. 38:1834-1837.
6. Beauvais, B., C. Sarfati, S. Challier, and F. Derouin. 1994. In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi. Antimicrob. Agents Chemother. 38:2440-2448.
7. Blanshard, C., D. S. Ellis, D. G. Tovey, S. Dowell, and B. G. Gazzard. 1992. Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS 6:311-313.
8. Cruz, M. C., M. S. Bartlett, and T. D. Edlind. 1994. In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles. Antimicrob. Agents Chemother. 38:378-380.
9. De Groote, M. A., G. Visvesvara, M. L. Wilson, N. J. Pieniazek, S. B. Slemenda, A. J. da Silva, G. J. Leitch, R. T. Bryan, and R. Reves. 1995. Polymerase chain reaction and culture confirmation of disseminated Encephalitozoon cuniculi in a patient with AIDS: successful therapy with albendazole. J. Infect. Dis. 171:1375-1378.
10. Didier, E. S., L. B. Rogers, J. M. Orenstein, M. D. Baker, C. R. Vossbrinck, T. van Gool, R. Hartskeerl, R. Soave, and L. M. Beaudet. 1996. Characterization of Encephalitozoon (Septata) intestinalis isolates cultured from nasal mucosa and bronchoalveolar lavage fluids of two AIDS patients. J. Eukaryot. Microbiol. 43:34-43.
11. Dieterich, D. T., E. A. Lew, D. P. Kotler, M. A. Poles, and J. M. Orenstein. 1994. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J. Infect. Dis. 169:178-183.
12. Ditrich, O., Z. Kuceroba, and B. Koudela. 1994. In vitro sensitivity of Encephalitozoon cuniculi and E. hellem to albendazole. J. Eukaryot. Microbiol. 41:37S.
13. Franssen, F. F. J., J. T. Lumeij, and F. van Knapen. 1995. Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. Antimicrob. Agents Chemother. 39:1265-1268.
14. 13a. Graybill, J. Personal communication.
15. Hardin, T. C., L. K. Najvar, J. Rizzo, M. G. Rinaldi, and J. R. Graybill. 1995. Discrepancy between in vitro & in vivo antifungal activity of albendazole, abstr. B-69, p. 38. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Hartskeerl, R. A., T. van Gool, A. R. Schuitema, E. S. Didier, and W. J. Terpstra. 1995. Genetic and immunological characterization of the microsporidian Septata intestinalis Cali, Kotler and Orenstein, 1993: reclassification to Encephalitozoon intestinalis. Parasitology 110:277-285.
17. Joste, N. E., J. D. Rich, K. J. Busam, and D. A. Schwartz. 1996. Autopsy verification at Encephalitozoon intestinalis (microsporidiosis) eradication following albendazole therapy. Arch. Pathol. Lab. Med. 120:199-203.
18. Kamaishi, T., T. Hashimoto, Y. Nakamura, F. Nakamura, S. Murata, N. Okada, K. Okamoto, M. Shimizu, and M. Hasegawa. 1996. Protein phylogeny of translation elongation factor EF-1α suggests microsporidians are extremely ancient eukaryotes. J. Mol. Evol. 42:257-263.
19. Katiyar, S. K., V. R. Gordon, G. L. McLaughlin, and T. D. Edlind. 1994. Antiprotozoal activities of benzimidazoles and correlations with β-tubulin sequence. Antimicrob. Agents Chemother. 38:2086-2090.
20. Keeling, P. J., and W. F. Doolittle. 1996. Alpha-tubulin from early-diverging eukaryotic lineages and the evolution of the tubulin family. Mol. Biol. Evol. 13:1297-1305.
21. Lacey, E. 1988. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 18:885-936.
22. Li, J., S. K. Katiyar, and T. D. Edlind. 1996. Site-directed mutagenesis of Saccharomyces cerevisiae β-tubulin: interaction between residue 167 and benzimidazole compounds. FEBS Lett. 385:7-10.
23. Li, J., S. K. Katiyar, A. Hamelin, G. S. Visvesvara, and T. D. Edlind. 1996. Tubulin genes from AIDS-associated microsporidia and implications for phylogeny and benzimidazole sensitivity. Mol. Biochem. Parasitol. 78:289-295.
24. Molina, J. M., E. Oksenhendler, B. Beauvais, C. Sarfati, A. Jaccard, F. Derouin, and J. Modai. 1995. Disseminated microsporidiosis due to Seplata intestinalis in patients with AIDS: clinical features and response to albendazole therapy. J. Infect. Dis. 171:245-249.
25. Orenstein, J. M., D. T. Dietrich, E. A. Lew, and D. P. Kotler. 1993. Albendazole as a treatment for disseminated microsporidiosis due to Septata intestinalis in AIDS patients: a report of four patients. AIDS 7:S40.
26. Van den Bossche, H., F. Rochette, and C. Horig. 1982. Mebendazole and related anthelmintics. Adv. Pharmacol. Chemother. 19:67-120.
27. van Gool, T., E. U. Canning, H. Gilis, M. A. van den Bergh Weerman, J. K. Eeftinck Schaltenkerk, and J. Dankert. 1994. Septata intestinalis frequently isolated from stool of AIDS patients with a new cultivation method. Parasitology 109:281-289.
28. Visvesvara, G. S., A. J. da Silva, G. P. Croppo, N. J. Pieniazek, G. J. Leitch, D. Ferguson, H. de Moura, S. Wallace, S. B. Slemenda, I. Tyrrell, D. F. Moore, and J. Meador. 1995. In vitro culture and serologic and molecular identification of Septata intestinalis isolated from urine of a patient with AIDS. J. Clin. Microbiol. 33:930-936.
29. Vossbrinck, C. R., J. V. Maddox, S. Friedman, B. A. Debrunner-Vossbrinck, and C. R. Woese. 1987. Ribosomal RNA sequence suggests microsporidia arc extremely ancient eukaryotes. Nature 326:411-414.
30. Weber, R., R. T. Bryan, D. A. Schwartz, and R. L. Owen. 1994. Human microsporidial infections. Clin. Microbiol. Rev. 7:426-461.
31. Weber, R., A. Mathis, P. Deplazes, B. Sauer, D. Steiner, G. S. Visvesvara, J. Eckert, and R. Luthy. 1994. Immunological and molecular analyses of Encephalitozoon hellem (Microsporidia) isolated from the urine of an HIV-infected patient with acute urinary tract infection. Successful treatment with albendazole, abstr. M-23, p. 198. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
32. Weber, R., B. Sauer, M. A. Spycher, P. Deplazes, R. Keller, R. Ammann, J. Briner, and R. Luthy. 1994. Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole. Clin. Infect. Dis. 19:342-345.